GlassScriptPhysician profile
Vy P Nguyen
NPI 1881671154
$11,163.53
in general payments reported to CMS, 2019-2025
54 companies · $1,599 in 2025
The $1,599 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,561 · 2020: $753 · 2021: $1,343 · 2022: $1,390 · 2023: $1,649 · 2024: $1,868 · 2025: $1,599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,116.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,309.13 | 2019-2025 | |
| Abbvie INC. | $1,219.23 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,209.95 | 2019-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Amgen INC. | $1,065.87 | 2019-2025 | Otezla, Repatha, Prolia |
| Lilly USA, LLC | $899.83 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $698.98 | 2019-2024 | Farxiga, Airsupra |
| Novo Nordisk INC | $593.31 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $423.07 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $364.78 | 2019-2024 | Xarelto |
| Astellas Pharma US INC | $279.87 | 2019-2025 | Veozah |
| Amarin Pharma, INC. | $251.56 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $230.81 | 2019-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Allergan, INC. | $158.65 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $155.03 | 2022-2023 | |
| Exact Sciences Corporation | $151.75 | 2023-2025 | Cologuard Collection Kit |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vy Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.